Cirrus Bio

Curated by Signal

Developer of multi omic solutions for the diagnosis and management of diseases

Overview

Developer of multi omic solutions for the diagnosis and management of diseases. The company uses proprietary artificial intelligence and a multi-omics approach, combining various technologies like next-generation sequencing, gene expression, and proteomics to develop innovative diagnostic solutions for lung cancer.

Key facts

Founded: 2021
Headquarters: Phoenix, United States
Stage: Sign up to view
Industry: Life Sciences Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Genome Connect
Online patient registry for researchers & clinicians
Life Sciences TechnologySan Mateo, United States
GeoProtein
Provider of protein bars
Life Sciences TechnologyBoston, United States
GenomeDiver
Online platform for genome based diagnostics
Life Sciences TechnologyNew York City, United States

About Cirrus Bio

What does Cirrus Bio do?

Developer of multi omic solutions for the diagnosis and management of diseases.

Where is Cirrus Bio headquartered?

Cirrus Bio is headquartered in Phoenix, United States.

When was Cirrus Bio founded?

Cirrus Bio was founded in 2021.

Which sector is Cirrus Bio in?

Cirrus Bio operates in Life Sciences Technology.

Who are Cirrus Bio's competitors?

Companies similar to Cirrus Bio include Genome Connect, GeoProtein, and GenomeDiver.